Showing 6,221 - 6,240 results of 7,608 for search '"oncology"', query time: 0.17s Refine Results
  1. 6221

    A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma by Margaret Hux, Denise Zou, Esprit Ma, Peter Sajosi, Andreas Engstrom, Ross Selby, Eugene Benson, Andrew Briggs, Vijayveer Bonthapally

    Published 2016-10-01
    “…Conversely, considering only patients with Eastern Corporative Oncology Group performance status of 0 or 1 increased the ICER to approximately £38 200. …”
    Get full text
    Article
  2. 6222
  3. 6223
  4. 6224
  5. 6225
  6. 6226
  7. 6227
  8. 6228
  9. 6229

    Age and serum anti-Müllerian hormone levels as predictors of time to return of menses after chemotherapy by Madhavi-Priya Singh, Rashi Kalra, Franca Agresta, Alec Leos, Samith Minu Alwis, Alex Polyakov, Genia Rozen, Kate Stern

    Published 2025-01-01
    “…This retrospective cohort study examined oncology patients (n = 67) who underwent chemotherapy and were treated through the Reproductive Services Unit of two institutions in Melbourne, Australia. …”
    Get full text
    Article
  10. 6230
  11. 6231
  12. 6232
  13. 6233
  14. 6234
  15. 6235

    Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome by Lukas Anschuetz, Ralph Hohenberger, Christoph Kaecker, Olgun Elicin, Roland Giger, Marco Caversaccio

    Published 2023-04-01
    “…Abstract Background To assess a large patient cohort with sinonasal malignancies focusing on regional involvement, recurrence and oncological outcome. Methods Patients (n = 144) with malignant tumors of the nasal cavity and paranasal sinuses were treated at our tertiary referral center between 2008 and 2019. …”
    Get full text
    Article
  16. 6236
  17. 6237
  18. 6238
  19. 6239

    Multifunctional Proteins Bridge Mitosis with Motility and Cancer with Inflammation and Arthritis by Jihong Jiang, Rosaely Casalegno-Garduno, Helen Chen, Anita Schmitt, Michael Schmitt, Christopher A. Maxwell

    Published 2010-01-01
    “…In particular, the multifunctional nature of HMMR/RHAMM and survivin will be highlighted and compared, as these molecules are the subject of extensive biological and therapeutic investigations within hematology and oncology fields. For these and other genes/proteins, we will highlight points of structural and functional intersection during cellular division and differentiation, as well as states associated with cancer, such as tumor-initiation and epithelial-to-mesenchymal transition (EMT). …”
    Get full text
    Article
  20. 6240

    Comparisons of CVID and IgGSD: Referring Physicians, Autoimmune Conditions, Pneumovax Reactivity, Immunoglobulin Levels, Blood Lymphocyte Subsets, and HLA-A and -B Typing in 432 Ad... by James C. Barton, Luigi F. Bertoli, J. Clayborn Barton

    Published 2014-01-01
    “…Using univariable analyses, we compared observations in 34 CVID and 398 IgGSD adult index patients (81.9% women) referred to a hematology/oncology practice. Similarities included specialties of referring physicians, mean ages, proportions of women, reactivity to Pneumovax, median serum IgG3 and IgG4 levels, median blood CD56+/CD16+ lymphocyte levels, positivity for HLA-A and -B types, and frequencies of selected HLA-A, -B haplotypes. …”
    Get full text
    Article